Locate your nearest distributor

Text search:
Forgot password?

News Archive

Simultaneous testing of GastroPanel® biomarkers is possible – preliminary study results have been completed

03.08.2016 09:30

Biohit Oyj Press Release August 3, 2016 at 09:30 am local time (EEST)
In accordance with the licensing agreement signed in 2013 between Biohit Oyj and clinical diagnostic company Randox Laboratories Ltd., an initial study investigating the simultaneous determination of Biohit GastroPanel® biomarkers using Randox Biochip Array Technology (BAT) has now been completed. According to preliminary study results, BAT simultaneously detects three key GastroPanel® biomarkers from a single patient sample. This multi-analytical approach would result in GastroPanel® becoming a more cost-effective, user-friendly test for diagnosis of dyspeptic symptoms and the screening of gastric cancer risk.
Read more